List of Essential Medicines from the World Health Organization
The list of essential medicines of the World Health Organization ( WHO Model List of Essential Medicines ) contains active substances and their preparations are classified as essential drugs are classified. According to the definition of the World Health Organization (WHO), these can satisfy the most urgent needs of a population for medical care. The model list is intended as a recommendation for governments of individual states to develop their own supply standards that are adapted to national guidelines and regional circumstances. By the end of 2003, 156 states had developed official lists of essential medicines.
Explanations
- The selection of the substances is made by the Expert Committee on the Selection and Use of Essential Medicines . The list is revised every two years; the current version is 21 June 2019. It was first published in 1977.
- The active substances contained in the main list ( core list ) are required according to the WHO for the operation of a basic health system. They are designed to be the most efficient, safest, and most cost-effective remedies for major diseases.
- Complementary active substances ( Complementary List ) concern diseases that require special diagnostics and special therapeutic options. Less cost-effective resources are also managed as complementary.
- The WHO marks active ingredients with a square symbol (□) for which the use of an alternative active ingredient with comparable therapeutic properties and the same level of safety is possible. This should be determined when the list is adopted and adapted to national circumstances based on these considerations and on the basis of the price and availability.
- A separate list for children ( WHO Model List of Essential Medicines for Children ) has been published since 2007, in its sixth edition in 2017. In the 16th version of the general list, instructions for use in children have been added.
Table of Medicines
1 anesthetics
Surname | recommended form of application | World Health Organization indications | Year of admission |
---|---|---|---|
1.1 - General anesthetics and oxygen | |||
1.1.1 Inhalation anesthetics | |||
Halothane | inhalation | Inhalation anesthetic to induce and maintain general anesthesia ( general anesthesia) | 1997 |
Isoflurane | inhalation | Inhalation anesthetic to induce and maintain general anesthesia ( general anesthesia) | 2011 |
Laughing gas | inhalation | Maintenance of general anesthesia in combination with other anesthetics; Analgesia in obstetrics , injuries and pain in palliative medicine | 1977 |
oxygen | inhalation | Maintenance of oxygen supply during anesthesia, use in newborns and children, for resuscitation and for the treatment of breathing disorders | 1979 |
1.1.2 Injection anesthetics | |||
Ketamine | injection | Induction and maintenance of general anesthesia, painkillers | 1985 |
Propofol | injection | Induction of general anesthesia (replaces the thiopental , which has been listed since 1977, in 2011 , this is still mentioned as an alternative) | 2011 |
1.2 - local anesthetics | |||
Bupivacaine | injection | Long-acting local anesthetic for infiltration anesthesia, peripheral and sympathetic nerve blocks , spinal and epidural anesthesia | 1977 |
Lidocaine | Injection, topical formulation | Local anesthesia , dental procedures , spinal anesthesia | 1977 |
Lidocaine + adrenaline | injection | Local anesthesia , especially for dental procedures, not for procedures on the finger | 1979 |
Ephedrine (complementary) | injection | Therapy of blood pressure drops during spinal anesthesia for caesarean section | 1998 |
1.3 - premedication and sedation | |||
Atropine | injection | Premedication to prevent bradycardia | 1988 |
Midazolam | Injection, juice, tablet | Premedication before surgical interventions, sedation with amnesia for endoscopic examinations and interventions under local anesthesia (replaces diazepam, which has been listed since 1985 in 2011 ) | 2011 |
Morphine | injection | Painkiller | 1988 |
1.4 - Medical gases | |||
oxygen | inhalation | Management of oxygen demand, avoidance of hypoxemia (no more than 30% oxygen should be used to initiate resuscitation of newborns born in or before the 32nd week of pregnancy ) | 2017 (new indication) |
2 analgesics
Surname | recommended form of application | World Health Organization indications | Year of admission |
---|---|---|---|
2.1 Non-opioid analgesics and non-steroidal anti-inflammatory drugs | |||
Acetylsalicylic acid | Tablet, suppository | Slight pain, fever | 1977 |
Ibuprofen | Juice, tablet | Slight pain, fever | 1977 |
Paracetamol | Juice, tablet, suppository | Slight pain, fever | 1977 |
2.2 Opioid analgesics | |||
Codeine | tablet | Low potency analgesic for mild to moderate pain | 1985 |
Fentanyl | Transdermal patch | Cancer pain | 2017 |
Morphine | Granules, injection, juice, tablet, prolonged-release tablet | Highly potent analgesic for postoperative use and for severe pain | 1977 |
Methadone
(complementary) |
Tablet, oral solution | Cancer pain | 2017 (new indication) |
2.3 Medicines used in palliative medicine | |||
Amitriptyline | tablet | 2011 | |
Cyclizine | Injection, tablet | 2011 | |
Dexamethasone | Injection, juice, tablet | 2011 | |
Diazepam | Injection, juice, tablet, rectal gel | 2011 | |
Docusate sodium | Capsule, juice | 2011 | |
Fluoxetine | Solid oral form | 2011 | |
Haloperidol | Injection, solid or liquid oral form | 2013 | |
Butylscopolamine bromide | injection | 2013 | |
Scopolamine hydrobromide | Transdermal patch, injection | 2011 | |
Lactulose | juice | 2011 | |
Loperamide | Solid oral form | 2013 | |
Metoclopramide | Injection, solid or liquid oral form | 2013 | |
Midazolam | Injection, solid or liquid oral form | 2011 | |
Ondansetron | Injection, solid or liquid oral form | 2011 | |
Senna | juice | 2011 |
3 Therapy of allergy and anaphylaxis
Surname | recommended form of application | World Health Organization indications | Year of admission |
---|---|---|---|
Dexamethasone | injection | Corticosteroid used to treat allergy and anaphylaxis | 1985 |
adrenaline | injection | severe anaphylaxis, severe angioedema | 1988 |
Hydrocortisone | Powder for injection | Combination with adrenaline in anaphylactic shock | 1988 |
Loratadine | Juice, tablet | Suppression of histamine effects for special indications | 2013 |
Prednisolone | Juice, tablet | Anti-inflammatory in allergic diseases | 1985 |
4 antidotes
Surname | recommended form of application | World Health Organization indications | Year of admission |
---|---|---|---|
4.1 Non-specific antidotes | |||
Activated carbon | powder | Antidote for acute peroral poisoning | 1977 |
4.2 Specific antidotes | |||
Acetylcysteine | Injection, juice | Antidote for acetaminophen poisoning | 2000 |
Atropine | injection | Antidote for organophosphate poisoning | 1997 |
Calcium gluconate | injection | Treatment of magnesium toxicity | 1998 |
Methylene blue | injection | acute methemoglobinemia | 1985 |
Naloxone | injection | Opioid antidote | 1983 |
Penicillamine | Capsule or tablet | Lead poisoning | 1985 |
Iron (III) hexacyanoferrate | Powder for oral administration | Thallium poisoning | 1990 |
Sodium nitrite | injection | Antidote for cyanide poisoning | 1979 |
Sodium thiosulfate | injection | Antidote for cyanide poisoning | 1977 |
Deferoxamine (complementary) | Powder for injection | Treatment of acute iron poisoning and chronic iron and aluminum overload | 1979 |
Dimercaprol (complementary) | injection | Treatment of heavy metal poisoning , except iron, cadmium or selenium | 1977 |
Fomepizole (complementary) | injection | Treatment of poisoning with ethylene glycol or methanol | 2013 |
EDTA (complementary) | injection | Heavy metal poisoning, lead poisoning | 1979 |
Succimer (complementary) | Tablet or capsule | Heavy metal poisoning | 2011 |
5 anti-epileptic drugs
Surname | recommended form of application | World Health Organization indications | Year of admission |
---|---|---|---|
Carbamazepine | Juice, chewable tablet or divisible tablet | Generalized tonic-clonic and focal seizures , trigeminal neuralgia | 1988 |
Diazepam | rectal gel or suppository | Status epilepticus | 1977 |
Lamotrigine | Tablet, chewable or dispersible tablet | As a complementary therapy for therapy-resistant partial or generalized seizures. | 2017 |
Lorazepam | Solution for injection | 2009 | |
Magnesium sulfate | injection | Eclampsia , severe preeclampsia , not with other epileptic diseases | 2003 |
Midazolam | injection | 2015 | |
phenobarbital | Injection, juice, tablet | All forms of epilepsy , except for absenteeism | 1977 |
Phenytoin | Injection, solid or liquid oral form, chewable tablet | All forms of epilepsy, except for absenteeism | 1977 |
Valproate | Juice, tablet | Control of epilepsy | 1979 |
Ethosuximide (complementary) | Capsule, juice | Absence | 1977 |
Valproic acid (complementary) | injection | 2015 |
6 active ingredients against infectious diseases
Surname | recommended form of application | World Health Organization indications | Year of admission |
---|---|---|---|
6.1 anthelmintics ( anthelmintics ) | |||
6.1.1 Intestinal anthelmintics | |||
Albendazole | tablet | Treatment of various worm diseases : echinococcosis (if not surgically accessible), cysticercosis , infections with hookworms and roundworms , ascariasis , strongyloidiasis , enterobiasis , trichuriasis , capillary disease , filariasis | 1990 |
Ivermectin | tablet | 2017 (new indication) | |
Levamisole | tablet | Treatment of roundworm and roundworm infections | 1988 |
Mebendazole | tablet | Treatment of worm diseases with grub , thread , and hookworms | 1977 |
Niclosamide | tablet | Treatment of tapeworm infections | 1977 |
Praziquantel | tablet | Treatment of sucking and tapeworm infections | 1985 |
Pyrantel | Juice, tablet | Treatment of worm diseases with pinworms , whipworms and hookworms | 1983 |
6.1.2 Remedies against roundworms | |||
Albendazole | tablet | Treatment of various worm diseases : echinococcosis (if not surgically accessible), cysticercosis , infections with hookworms and roundworms , ascariasis , strongyloidiasis , enterobiasis , trichuriasis , capillary disease , filariasis | 1990 |
Diethylcarbamazine | tablet | Treatment of filariasis, including loiasis | 1977 |
Ivermectin | tablet | Treatment of onchocerciasis and filariasis | 1988 |
6.1.3 Remedies against Schistosoma (pair of leeches ) and Trematoda (flukes) | |||
Praziquantel | tablet | Treatment of schistosomiasis (schistosomiasis) of the intestinal and urogenital tract | 1983 |
Triclabendazole | tablet | Treatment of fasciolosis and paragonimiasis | 1977 |
Oxamniquine (complementary) | Capsule, juice | Treatment of infections with Schistosoma mansoni | 1997 |
6.2 Antibacterial agents ( antibiotics ) | |||
6.2.1 Access group | |||
Amikacin | injection | Treatment of pyelonephritis and neutropenia | 2019 |
Amoxicillin | Capsule, powder | Treatment of a wide range of pathogens in acute respiratory infections , urinary tract infections , sinusitis , infections with chlamydia or Helicobacter pylori | 1990 |
Amoxicillin + clavulanic acid | Juice, tablet | Infections with β-lactamase- producing germs | 1998 |
Ampicillin | Powder for injection | Treatment of peritonitis , meningitis , endocarditis | 1977 |
Benzathine benzyl penicillin | Powder for injection | Prophylaxis of rheumatic fever , syphilis , diphtheria | 1977 |
Benzyl penicillin | Powder for injection | Treatment of infections with streptococci , meningococci , treponemas | 1977 |
Cefalexin | Capsule, powder for juice | (Use in children) | 2009 |
Cefazolin | Powder for injection | Prophylaxis of surgical infections | k. A. |
Chloramphenicol | Capsule, juice, solution for injection, powder for injection | Treatment of infections with various bacteria, including Haemophilus influenzae , Salmonella typhi , Borrelia , meningitis with meningococci | 1977 |
Clindamycin | Solution for injection, capsule, juice | Infections | 1992 |
Cloxacillin | Capsule, powder for juice, powder for injection | Penicillinase -solid active ingredient for the treatment of various staphylococcal infections | 1977 |
Doxycycline | Capsule, juice, powder for injection | Tetracycline , used in a variety of infections, especially in the case of chlamydia , lymphogranuloma venereum , typhoid and Lyme borreliosis | 1977 |
Gentamicin | Solution for injection | Aminoglycoside with a broad spectrum of activity | 1977 |
Metronidazole | Solution for injection, juice, tablet, suppository | Active ingredient from the group of nitroimidazoles against anaerobic pathogens | 1979 |
Nitrofurantoin | Juice, tablet | Antibiotic for urinary tract infections , including prophylactic use | 1979 |
Phenoxymethylpenicillin | Powder for juice, tablet | Treatment of infections of the ENT area ( tonsillitis , otitis media ) and the skin ( erysipelas , cellulitis ), rheumatic fever | 1977 |
Procaine - Benzylpenicillin | Powder for injection | Long-acting antibiotic used to treat a wide variety of infectious diseases (syphilis, child pneumonia, anthrax , diphtheria, bite wounds) | 1983 |
Spectinomycin | Powder for injection | Aminoglycoside, effective in various infections as a substitute for cephalosporins or quinolone antibiotics | 1977 |
Sulfamethoxazole + trimethoprim (corresponds to co- trimoxazole ) | Solution for injection, juice, tablet | Combination of active ingredients for use in infections of the respiratory and urinary tract | 1977 |
6.2.2 Watch group | |||
Azithromycin | Capsule, juice | Macrolide antibiotic , only listed for single-dose applications in use in infections of the eye ( trachoma ) or genital region with Chlamydia trachomatis | 2003 |
Cefixime | capsule | Treatment of gonorrhea | 2005 |
Cefotaxime | Powder for injection | Third generation cephalosporin , the drug of choice in newborns | 2009 |
Ceftriaxone | Powder for injection | Treatment of meningitis due to various pathogens | 2005 |
Cefuroxime | Powder for injection | prophylaxis | 2019 |
Ciprofloxacin | Infusion solution, juice, tablet | Gyrase inhibitors for the treatment of cholera , shigellosis , typhoid and gonorrhea, among others | 1990 |
Clarithromycin | Tablet, capsule, powder for injection, soluble powder as juice | Combination therapy for Helicobacter pylori eradication | 2011 |
Piperacillin + tazobactam | Powder for injection | Treatment of intra-abdominal infections, neutropenia and pneumonia | 2019 |
Vancomycin | capsule | Active ingredient against Clostridium difficile | 1997 |
Ceftazidime (complementary) | Powder for injection | Active ingredient against Pseudomonas aeruginosa | 1997 |
Meropenem (complementary) | Powder for injection | Reserve agent with a broad spectrum of action against multi-resistant pathogens | 2019 |
Vancomycin (complementary) | Powder for injection | Reserve active ingredient against resistant germs, including MRSA | 1997 |
6.2.3 Reserve group | |||
Ceftazidime + avibactam (complementary) | Powder for injection | 2019 | |
Colistin (complementary) | Powder for injection | 2019 | |
Fosfomycin (complementary) | Powder for injection | 2019 | |
Linezolid (complementary) | Powder for injection, solution for injection, tablet | 2019 | |
Meropenem + Vaborbactam (complementary) | Powder for injection | 2019 | |
Plazomicin (complementary) | Solution for injection | 2019 | |
Polymyxin B (complementary) | Powder for injection | 2019 | |
6.2.4 Leprosy drugs | |||
Clofazimine | capsule | Treatment of lepromatous leprosy as part of combination therapy | 1979 |
Dapsone | tablet | Treatment of all forms of leprosy as part of combination therapy | 1979 |
Rifampicin | Capsule, tablet | Treatment of leprosy as part of combination therapy | 1977 |
6.2.5 Tuberculostatics | |||
Ethambutol | Juice, tablet | Treatment of tuberculosis (TB) as part of combination therapy | 1977 |
Ethambutol + isoniazid + rifampicin | tablet | Combination therapy for the treatment of tuberculosis | 2007 |
Ethambutol + isoniazid + pyrazinamide + rifampicin | tablet | Combination therapy for the treatment of tuberculosis | 2000 |
Isoniazid | Juice, tablet | Treatment of tuberculosis as part of combination therapy, TB prophylaxis | 1977 |
Isoniazid + pyrazinamide + rifampicin | tablet | Combination therapy for the treatment of tuberculosis | 1997 |
Isoniazid + rifampicin | tablet | Combination therapy for the treatment of tuberculosis | 1990 |
Pyrazinamide | Juice, tablet | Treatment of tuberculosis as part of combination therapy | 1983 |
Rifabutin | capsule | Treatment of tuberculosis in the presence of HIV | 2011 |
Rifampicin | Capsule, juice, tablet | Treatment of tuberculosis as part of combination therapy | 1977 |
Rifapentine | tablet | Treatment of latent tuberculosis (LTBI) | |
Amikacin (complementary) | Powder for injection | Treatment of multi-drug resistant tuberculosis (MDR-TB) | 2002 |
Amoxicillin + clavulanic acid (complementary) | Juice, tablet | 2019 | |
Bedaquiline (complementary) | tablet | Treatment of multi-drug resistant tuberculosis (MDR-TB) | 2015 |
Capreomycin (complementary) | Powder for injection | Treatment of multi-resistant tuberculosis in special centers | 2002 |
Clofazimin (complementary) | Capsule, tablet | 2019 | |
Cycloserine (complementary) | Capsule, tablet | Second choice drug for multidrug-resistant tuberculosis tuberculosis | 2000 |
Delamanid (complementary) | tablet | Second choice drug for multidrug-resistant tuberculosis | 2015 |
Ethionamide (complementary) | tablet | Reserve medication for multi-drug resistant tuberculosis; Prothionamide can be used as an alternative to ethionamide. | 2000 |
Levofloxacin (complementary) | tablet | Reserve medication for multi-drug resistant tuberculosis; Ofloxacin and moxifloxacin can be used as alternatives to levofloxacin. | 2002 |
Linezolid (complementary) | Injection, Soluble Powder as Juice, Tablet | 2015 | |
Meropenem (complementary) | Powder for injection | 2019 | |
Moxifloxacin (complementary) | tablet | 2019 | |
Paraaminosalicylic acid (complementary) | Granules or tablets | Reserve drug for multidrug-resistant tuberculosis | 2002 |
Streptomycin (complementary) | Powder for injection | Treatment of tuberculosis as part of combination therapy | 1977 |
6.3 Active substances against fungal infections ( antimycotics ) | |||
Amphotericin B | Powder for injection | Treatment of life-threatening fungal infections such as histoplasmosis , coccidioidomycosis , paracoccidioidomycosis , blastomycosis , aspergillosis , cryptococcosis , mucormycosis , sporotrichosis and candidiasis | 2003 |
Clotrimazole | Vaginal cream or vaginal tablet | Candidiasis of the vulva or vagina | 2005 |
Fluconazole | Capsule, injection, juice | Broad spectrum antifungal agent | 1998 |
Flucytosine | Capsule, infusion | Treatment of systemic yeast and fungal diseases | 1977 |
Griseofulvin | Capsule, juice, tablet | Treating skin, hair, and nail infections when topical treatment has failed. | 1977 |
Itraconazole | Capsule, oral solution | Treatment of chronic pulmonary aspergillosis, histoplasmosis , sporotrichosis , Parakokkidiodomykose, by T. marneffei mycoses caused and Chromoblastomykosen; Prophylaxis of histoplasmosis and T. marneffei infections in AIDS patients. | 2017 |
Nystatin | Juice, tablet, pessary | Candidiasis of the skin and mucous membranes | 1979 |
Voriconazole | Tablet, powder for solutions for injection or oral use | Treatment of chronic pulmonary aspergillosis and acute invasive aspergillosis | 2017 |
Potassium iodide (complementary) | solution | Treatment of cutaneous sporotrichosis | 1997 |
6.4 Antiviral drugs ( virostatics ) | |||
6.4.1 Herpes Therapy | |||
Acyclovir | Juice, powder for injection, tablet | Treatment of genital herpes ( herpes simplex infection ), treatment of chickenpox in immunocompromised people | 1998 |
6.4.2 Antiretroviral Therapy | |||
6.4.2.1 Nucleosidic reverse transcriptase inhibitors | |||
Abacavir | Juice, tablets | Combination therapy for HIV infection | 2002 |
Lamivudine | Juice, tablet | Combination therapy for HIV infection | 2002 |
Tenofovir disoproxil fumarate | tablet | Combination therapy for HIV infection | 2007 |
Zidovudine | Injection, capsule, juice, tablet | Combination therapy for HIV infection. Prophylaxis of the transmission of the virus from mother to fetus | 1998 |
6.4.2.2 Non-nucleoside reverse transcriptase inhibitors | |||
Efavirenz | tablet | Combination therapy for HIV infection with at least two other drugs | 2002 |
Nevirapine | Juice, tablet | Combination therapy for HIV infection with at least two other drugs | 2000 |
6.4.2.3 Protease inhibitors | |||
Atazanavir | capsule | Combination therapy for HIV infection | |
Atazanavir + ritonavir | Juice, tablet, capsule | 2019 | |
Darunavir | tablet | 2015 | |
Lopinavir + ritonavir | Capsule, juice, tablet | Combination therapy for HIV infection | 2002 |
Ritonavir | Capsule, juice, tablet | Combination therapy for HIV infection | 2002 |
6.4.2.4 Integrase inhibitors | |||
Dolutegravir | tablet | 2019 | |
Raltegravir | Tablet, granules | Treatment of pregnant women | 2019 |
Combination preparations, cf. Highly active antiretroviral therapy | |||
Abacavir + lamivudine | tablet | 2015 | |
Dolutegravir + lamivudine + tenofovir | tablet | 2019 | |
Efavirenz + emtricitabine + tenofovir | tablet | (Combination therapy for HIV infection) | 2007 |
Efavirenz + lamivudine + tenofovir | tablet | 2019 | |
Emtricitabine + tenofovir | tablet | (Combination therapy for HIV infection) | 2007 |
Lamivudine + nevirapine + zidovudine | tablet | (Combination therapy for HIV infection) | 2007 |
Lamivudine + zidovudine | tablet | (Combination therapy for HIV infection) | 2007 |
6.4.2.5 Prevention of opportunistic HIV infections | |||
Isoniazid + pyridoxine + sulfamethoxazole + trimethoprim | tablet | 2019 | |
6.4.3 Other antivirals | |||
Ribavirin | Injection, capsule | Treatment of viral hemorrhagic fever | 2007 |
Valganciclovir | tablet | Treatment of CMV - retinitis | 2015 |
Oseltamivir (complementary) | Capsule, powder | Treatment of severe influenza H1N1 illness | 2011 |
Valganciclovir (complementary) | Tablet, powder | Treatment of CMV - retinitis | 2019 |
6.4.4 Anti-hepatitis agents | |||
6.4.4.1 Agents against hepatitis B | |||
6.4.4.1.1 Nucleosidic reverse transcriptase inhibitors | |||
Entecavir | Oral drops, tablets | Treatment of hepatitis B. | 2015 |
Tenofovir disoproxil fumarate | Tablets | Treatment of hepatitis B. | 2015 |
6.4.4.2 Agents against hepatitis C | |||
6.4.4.2.1 Pangenotypical direct-acting antiviral combinations | |||
Daclatasvir | Tablets | Treatment of hepatitis C. | 2015 |
Glecaprevir + pibrentasvir | tablet | 2019 | |
Sofosbuvir | Tablets | Treatment of hepatitis C. | 2015 |
Sofosbuvir + velpatasvir | tablet | ||
6.4.4.2.2 Direct acting antiviral combinations, which are not typical of panache | |||
Dasabuvir | Tablets | Treatment of hepatitis C. | 2015 |
Ledipasvir + sofosbuvir | Tablets | 2015 | |
Onbitasvir + paritaprevir + ritonavir | Tablets | 2015 | |
6.4.4.2.3 Other antivirals | |||
Ribavirin | iv injection / solid oral dosage forms | Treatment of hepatitis C, in combination with peginterferon or antiviral agents | 2015 |
Peginterferon α (complementary) | injection | Treatment of hepatitis C, in combination with ribavirin | 2015 |
6.5 Active substances against protozoa | |||
6.5.1 Amoeba and Giardia | |||
Diloxanide furoate | tablet | Treatment of amoebic dysentery in combination with other drugs, treatment of asymptomatic carriers | 1988 |
Metronidazole | Tablet, injection, juice | Infections with protozoa (amoebic dysentery, giardiasis ) | 1988 |
6.5.2 Leishmania | |||
Amphotericin B | Powder for injection | Treatment of the visceral (organ afflicting) and mucocutaneous (mucosal afflicting) form of leishmaniasis when antimony preparations (such as N-methyl-glucamine antimonate) are ineffective | 2003 |
Miltefosine | Capsule or tablet | 2011 | |
Paromomycin | Intramuscular injection | Treatment of the visceral and mucocutaneous forms of leishmaniasis | 2007 |
Sodium stibogluconate or N-methylglucamine antimonate | injection | Treatment of leishmaniasis (except infections with Leishmania aethiopica ) | 1988 |
6.5.3 Malaria | |||
6.5.3.1 curative | |||
Amodiaquine | tablet | Treatment of malaria ( Plasmodium vivax , Plasmodium ovale and Plasmodium malariae ), alone or in combination with artesunate | 1977 |
Artemether | injection | Treatment of Severe Malaria | 1997 |
Artemether + Lumefantrine | tablet | Treatment of uncomplicated malaria ( Plasmodium falciparum ) | 2002 |
Artesunate | Injection, rectal gel, tablet, suppository | Part of a combination therapy (with amodiaquine, mefloquine or sulfadoxine + pyrimethamine) for the treatment of malaria (Plasmodium falciparum) | 2002 |
Artesunate + amodiaquine | tablet | (Combination therapy for malaria) | 2011 |
Artesunate + mefloquine | tablet | (Combination therapy for malaria) | 2013 |
Artesunate + pyronaridine tetraphosphate | Tablet, granules | (Combination therapy for malaria) | 2017 |
Chloroquine | Juice, tablet | Only for treatment of malaria caused by Plasmodium vivax | 1977 |
Dihydroartemisinin + Piperaquinphosphat | tablet | (Combination therapy for malaria) | 2017 |
Doxycycline | Capsule, tablet | Only for the treatment of malaria in combination with quinine | 1997 |
Mefloquine | tablet | Part of a combination therapy (with Artenusat) for the treatment of uncomplicated malaria (Plasmodium falciparum) | 1988 |
Primaquine | tablet | Only for radical treatment of malaria triggered by Plasmodium vivax and / or Plasmodium ovale | 1977 |
quinine | Injection, tablet | Treatment of severe malaria in combination with doxycycline | 1977 |
Sulfadoxine + pyrimethamine | tablet | Only as part of a combination therapy (with Artenusat) | 1979 |
6.5.3.2 prophylactic | |||
Amodiaquine + sulfadoxine + pyrimethamine | tablet | 2019 | |
Chloroquine | Juice, tablet | Only for the prophylaxis of malaria in Central America against Plasmodium vivax | 1988 |
Doxycycline | Capsule, tablet | Malaria prophylaxis | 2000 |
Mefloquine | tablet | Malaria prophylaxis | 1995 |
Proguanil | tablet | Prophylaxis of malaria, only in combination with chloroquine | 1988 |
Sulfadoxine + pyrimethamine | tablet | 2019 | |
6.5.4 Pneumocystis and toxoplasmosis | |||
Pyrimethamine | tablet | Treatment of infections with Toxoplasma gondii , Pneumocystis jirovecii (in combination with sulfadiazine) | 1998 |
Sulfadiazine | tablet | Treatment of toxoplasmosis (in combination with pyrimethamine) | 1977 |
Sulfamethoxazole + trimethoprim
( Co-trimoxazole ) |
Injection, juice, tablet | Treatment of infections with Pneumocystis jirovecii | 1998 |
Pentamidine (complementary) | tablet | Treatment of infections with Toxoplasma gondii and / or Pneumocystis jirovecii | 1998 |
6.5.5 Trypanosomiasis | |||
6.5.5.1 African trypanosomiasis | |||
Fexinidazole | tablet | First and second stage of African trypanosomiasis , primarily infection with Trypanosoma brucei gambiense | 2019 |
First stage of African trypanosomiasis | |||
Pentamidine | Powder for injection | First stage of African trypanosomiasis , primarily infection with Trypanosoma brucei gambiense | 1977 |
Suramin | Powder for injection | First stage of African trypanosomiasis, exclusive to infection with Trypanosoma brucei rhodesiense | 1979 |
Second stage of African trypanosomiasis | |||
Eflornithine | injection | Second stage of African trypanosomiasis, secondary treatment for infections with Trypanosoma brucei gambiense | 1992 |
Melarsoprol | injection | Second stage of African trypanosomiasis | 1977 |
Nifurtimox | tablet | Second stage of African trypanosomiasis, only in combination with eflornithine | |
Melarsoprol (complementary) | injection | Second stage of African trypanosomiasis | 2019 |
6.5.5.2 American trypanosomiasis | |||
Benznidazole | tablet | Trypanosoma cruzi ( Chagas disease ) infection | 1988 |
Nifurtimox | tablet | Chagas disease | 1977 |
6.6 Active substances against ectoparasitic infections | |||
Ivermectin | tablet | 2019 |
7 migraine drugs
Surname | recommended form of application | World Health Organization indications | Year of admission |
---|---|---|---|
7.1 Therapy of an acute migraine attack | |||
Acetylsalicylic acid | tablet | acute migraine attack | 1988 |
Ibuprofen | tablet | acute migraine attack | 2007 |
Paracetamol | Juice, tablet | acute migraine attack | 1988 |
7.2 Migraine prophylaxis | |||
Propranolol | tablet | Migraine prophylaxis | 1990 |
8 Antineoplastic Agents and Immunosuppressants
Surname | recommended form of application | World Health Organization indications | Year of admission |
---|---|---|---|
8.1 Immunosuppressive agents | |||
Adalimumab (complementary) | injection | 2019 | |
Azathioprine (complementary) | Powder for injection, tablet | Prevention of transplant rejection . Second choice drug for chronic inflammatory diseases | 2002 |
Ciclosporin (complementary) | Capsule, concentrate for injection | Prevention of transplant rejection | 1992 |
8.2 Cytostatic agents for chemotherapy | |||
8.2.1 Cytotoxic agents | |||
Arsenic (III) oxide (complementary) | Concentrate for injection | Treatment of promyelocytic leukemia | 2019 |
Asparaginase (complementary) | Powder for injection | Cytostatic agent for the treatment of acute lymphocytic leukemia in childhood. | 1995 |
Bendamustine (complementary) | injection | Chronic lymphocytic leukemia , follicular lymphoma | 2015 |
Bleomycin (complementary) | Powder for injection | Treatment of various cancers including Hodgkin and non-Hodgkin lymphomas , head and neck cancers , cervical cancers , testicular tumors, and others | 1977 |
Calcium folinate (complementary) | Injection, tablet | High dosage or overdose of methotrexate ( folate rescue ). With fluorouracil as a palliative treatment for advanced colorectal cancer | 1977 |
Capecitabine (complementary) | tablet | Colon cancer, rectal cancer, metastatic breast and colorectal cancer | |
Carboplatin (complementary) | injection | (replaces cisplatin) | 2009 |
Chlorambucil (complementary) | tablet | Chronic lymphocytic leukemia , Hodgkin and non-Hodgkin lymphomas , ovarian carcinoma , Waldenström's disease | 1999 |
Cisplatin (complementary) | injection |
Non-small cell lung cancer , osteosarcoma , germ cell tumors .
As a radiosensitizer for cervical cancer , head and neck cancer and nasopharyngeal cancer . |
|
Cyclophosphamide (complementary) | Powder for injection, tablet | Treatment of various types of cancer including malignant lymphoma , leukemia , multiple myeloma , ovarian cancer , breast cancer | 1977 |
Cytarabine (complementary) | Powder for injection | Antimetabolite used to treat various forms of cancer | 1979 |
Dacarbazine (complementary) | Powder for injection | Palliative treatment of metastatic melanoma , part of the ABVD treatment regimen for Hodgkin's lymphoma | 1990 |
Dactinomycin (complementary) | Powder for injection | Treatment of various childhood cancers, including trophoblastic tumors, Wilms' tumor , Ewing's sarcoma , rhabdomyosarcoma | 1985 |
Daunorubicin (complementary) | Powder for injection | Treatment of various forms of cancer, especially acute leukemia | 2000 |
Docetaxel (complementary) | injection | 2011 | |
Doxorubicin (complementary) | Powder for injection | Treatment of various forms of cancer, including acute leukemia, carcinomas of the breast , bladder , ovaries and thyroid , lymphomas , sarcomas | 1977 |
Etoposide (complementary) | Capsule, injection | Treatment of various forms of cancer, including testicular and lung cancer | 1985 |
Fludarabine (complementary) | Powder for injection, tablet | Chronic lymphocytic leukemia | |
Fluorouracil (complementary) | injection | Treatment of various cancers including colorectal cancer , breast cancer, stomach cancer , head and neck cancer | 1977 |
Gemcitabine (complementary) | Powder for injection | Ovarian cancer , non-small cell lung cancer | |
Hydroxycarbamide (complementary) | Capsule, tablet | 2009 | |
Ifosfamide (complementary) | Powder for injection | 2009 | |
Irinotecan (complementary) | injection | Metastatic colorectal cancer | |
Melphalan (complementary) | Tablet, powder for injection | Treatment of multiple myelomas | 2019 |
Mercaptopurine (complementary) | tablet | Treatment of leukemia | 1985 |
Methotrexate (complementary) | Powder for injection, tablet | Treatment of various forms of cancer | 1977 |
Oxaliplatin (complementary) | Injection, powder for injection | Different types of colon cancer | |
Paclitaxel (complementary) | Powder for injection | 2011 | |
Pegaspargase (complementary) | injection | Treatment of acute lymphoblastic leukemia | 2019 |
Procarbazine (complementary) | capsule | Combination therapy for Hodgkin lymphoma | 1979 |
Realgar - Indigo (complementary) | tablet | Treatment of promyelocytic leukemia | 2019 |
Tioguanine (complementary) | Tablet or capsule | 2011 | |
Vinblastine (complementary) | Powder for injection | Treatment of leukemia and lymphoma, as well as some solid tumors such as breast and lung cancer | 1985 |
Vincristine (complementary) | Powder for injection | Treatment of leukemia and lymphoma, as well as some solid tumors such as breast and lung cancer | 1977 |
Vinorelbine (complementary) | injection | Breast cancer , non-small cell lung cancer | |
8.2.2 Targeted Therapy | |||
Bortezomib (complementary) | Powder for injection | Treatment of multiple myelomas | 2019 |
Dasatinib (complementary) | tablet | Imatinib-resistant chronic myeloid leukemia | 2017 |
Erlotinib (complementary) | tablet | Treatment of the EGFR T790M mutation | 2019 |
Imatinib (complementary) | tablet | Chronic myeloid leukemia , gastrointestinal stromal tumor | |
Nilotinib (complementary) | capsule | Imatinib-resistant chronic myeloid leukemia | 2017 |
Rituximab (complementary) | injection | Diffuse large B-cell lymphoma , chronic lymphocytic leukemia , follicular lymphoma | |
Trastuzumab (complementary) | Powder for injection | Treatment of early forms and metastatic HER2 -positive breast cancer | 2015 |
Tretinoin (complementary) | capsule | acute promyelocytic leukemia | 2015 |
8.2.3 immunomodulators | |||
Filgrastim (complementary) | injection | ||
Lenalidomide (complementary) | capsule | Treatment of multiple myelomas | 2019 |
Nivolumab (complementary) | Concentrate for infusion | Treatment of malignant melanoma | 2019 |
Thalidomide (complementary) | capsule | Treatment of multiple myelomas | 2019 |
8.2.4 Hormones and anti- hormones | |||
Abiraterone (complementary) | tablet | Treatment of metastatic castration-resistant prostate cancer | 2019 |
Anastrozole (complementary) | tablet | Breast cancer , early and metastatic stages | |
Bicalutamide (complementary) | tablet | Metastatic prostate cancer | |
Dexamethasone (complementary) | Injection, juice, tablet | Palliative use in advanced cancer as adjuvant therapy | k. A. |
Hydrocortisone (complementary) | Powder for injection | Synthetic hormone, adjuvant treatment of malignant tumors | 2003 |
Leuprorelin (complementary) | injection | Breast cancer , early and metastatic stages | |
Methylprednisolone (complementary) | injection | adjuvant treatment | 2011 |
Prednisolone (complementary) | Juice, tablet | In combination with cytostatics for acute lymphocytic leukemia and chronic lymphocytic leukemia as well as lymphomas | 1985 |
Tamoxifen (complementary) | tablet | Selective estrogen receptor modulator (antiestrogen) for the treatment of breast cancer | 1985 |
8.2.5 Supporting agents | |||
Allopurinol (complementary) | tablet | 2009 | |
Mesna (complementary) | Injection, tablet | 2009 | |
Zoledronic acid (complementary) | Infusion (concentrate) | Malignant diseases of the skeleton | 2017 |
9 Parkinson's Drugs
Surname | recommended form of application | World Health Organization indications | Year of admission |
---|---|---|---|
Biperiden | Injection, tablet | Treatment of parkinsonism , including drug-induced extrapyramidal symptoms | 1977 |
Levodopa + carbidopa | tablet | Combination treatment for Parkinson's disease | 1977 |
10 drugs of hematology
Surname | recommended form of application | World Health Organization indications | Year of admission |
---|---|---|---|
10.1 Treatment of anemia | |||
Iron salts | Juice, tablet | Iron Deficiency Anemia , Diet Supplements | 1977 |
Iron salts + folic acid | tablet | Food supplements during pregnancy , iron deficiency anemia | 1985 |
Folic acid | tablet | Treatment of folic acid deficiency ( megaloblastic anemia ) | 1977 |
Hydroxycobalamin | injection | Treatment of pernicious anemia due to vitamin B12 deficiency | 1977 |
Erythropoiesis-stimulating substances (complementary) | Pre-filled syringe | Chronic kidney failure anemia applies to: epoetin alfa, beta and theta, darbepoetin alfa, methoxypolyethylene glycol-epoetin beta and corresponding biosimilars | 2017 |
10.2 Drugs that modify blood clotting | |||
Dabigatran | capsule | 2019 | |
Enoxaparin | injection | Alternatively: nadroparin or dalteparin | |
Heparin Sodium | injection | Short-acting anticoagulant for the treatment and prophylaxis of deep vein thrombosis and pulmonary embolism | 1977 |
Phytomenadione | Injection, tablet | Prevention of vitamin K deficiency-related bleeding in the newborn, correction of blood coagulation during therapy with vitamin K antagonists | 1979 |
Protamine sulfate | injection | Antidote for heparin overdose | 1979 |
Tranexamic acid | injection | To inhibit fibrinolysis | 2011 |
Warfarin | tablet | Oral anticoagulation . Prophylaxis of embolizations , e.g. in the case of atrial fibrillation , after the implantation of artificial heart valves , treatment of venous thrombi and pulmonary embolism , use after a transitory ischemic attack | 1977 |
Desmopressin (complementary) | Injection, nasal spray | 2019 | |
Heparin sodium (complementary) | injection | Short-acting anticoagulant for the treatment and prophylaxis of deep vein thrombosis and pulmonary embolism | 1977 |
Protamine sulfate (complementary) | injection | Antidote for heparin overdose | 1979 |
Warfarin (complementary) | tablet | Oral anticoagulation . Prophylaxis of embolizations , e.g. in the case of atrial fibrillation , after the implantation of artificial heart valves , treatment of venous thrombi and pulmonary embolism , use after a transitory ischemic attack | 1977 |
10.3 Treatment of hemoglobinopathies | |||
Deferoxamine (complementary) | Powder for injection | alternatively deferasirox | 2011 |
Hydroxycarbamide (complementary) | Capsule, tablet | 2011 |
11 Blood Products and Plasma Substitutes
Surname | recommended form of application | World Health Organization indications | Year of admission |
---|---|---|---|
11.1 Blood and Blood Components | |||
Blood plasma | |||
Platelet rich plasma | |||
Erythrocyte | |||
blood | |||
11.2 Plasma Preparations | |||
11.2.1 Antibodies | |||
Anti-D immunoglobulin | injection | Prevention of antibody formation against Rh factor positive blood in Rh negative patients | 1977 |
Rabies immunoglobulin | injection | Post exposure prophylaxis | |
Tetanus immunoglobulin | injection | Passive immunization against tetanus ( tetanus ) in wounds with a corresponding risk | 1985 |
Human immunoglobulin (complementary) | intramuscular, intravenous, or subcutaneous injection | Treatment of congenital immune deficiencies , immune modulation in autoimmune diseases such as Guillain-Barré syndrome or Kawasaki syndrome | 2007 |
11.2.2 Coagulation factors | |||
Factor VIII concentrate (complementary) | Powder for injection | Replacement of factor VIII deficiency in haemophilia A. | 1979 |
Factor IX concentrate (complementary) | Powder for injection | Bleeding due to a lack of coagulation factors II , VII , IX , X ; Replacement of factor IX deficiency in hemophilia B | 1979 |
11.3 Plasma substitutes | |||
Dextran 70 | Solution for injection | Colloidal solution for infusion to increase plasma volume ; alternatively polygelin | 1977 |
12 Cardiovascular Drugs
Surname | recommended form of application | World Health Organization indications | Year of admission |
---|---|---|---|
12.1 Medicines for the treatment of angina pectoris | |||
Bisoprolol | tablet | (alternatively Carvedilol or Metoprolol ) | 2011 |
Glyceryl trinitrate | Sublingual tablet | Treatment of acute angina pectoris | 1977 |
Isosorbide dinitrate | Sublingual tablet | Prophylaxis and treatment of angina pectoris | 1977 |
Verapamil | tablet | Treatment of angina pectoris | 1983 |
12.2 Antiarrhythmics | |||
Bisoprolol | tablet | (alternatively Carvedilol or Metoprolol , 1992 to 2011 Atenolol ) | 2011 |
Digoxin | Injection, juice, tablet | Treatment of supraventricular arrhythmias , especially atrial fibrillation | 1998 |
adrenaline | injection | Cardiopulmonary resuscitation | 1998 |
Lidocaine | injection | Treatment of ventricular arrhythmias | 1977 |
Verapamil | Injection, tablet | Treatment of supraventricular tachycardia | 1988 |
Amiodarone (complementary) | Injection, tablet | (Treatment of ventricular and supraventricular arrhythmias) | 2009 |
12.3 Drugs for the treatment of arterial hypertension | |||
Amlodipine | tablet | Calcium antagonist used to treat arterial hypertension | 2005 |
Bisoprolol | tablet | Beta blockers for the treatment of arterial hypertension (alternatively carvedilol or metoprolol , 1992 to 2011 atenolol ) | 2011 |
Enalapril | tablet | ACE inhibitors used to treat arterial hypertension | 2003 |
Hydralazine | Powder for injection, tablet | Treatment of high blood pressure in pregnancy | 1977 |
Hydrochlorothiazide | Juice, capsule, tablet | Thiazide diuretic used to treat arterial hypertension | 1977 |
Lisinopril + amlodipine | tablet | 2019 | |
Lisinopril + hydrochlorothiazide | tablet | 2019 | |
Losartan | tablet | AT 1 antagonist for the treatment of high blood pressure . | 2017 |
Methyldopa | tablet | Treatment of high blood pressure in pregnancy | 1998 |
Telmisartan + amlodipine | tablet | 2019 | |
Telmisartan + hydrochlorothiazide | tablet | 2019 | |
Sodium nitroprusside (complementary) | Powder for injection | Treatment of the hypertensive crisis | 1988 |
12.4 Heart Failure Drugs | |||
Bisoprolol | tablet | (alternatively Carvedilol or Metoprolol ) | 2011 |
Digoxin | Injection, juice, tablet | Cardiac glycoside, used to treat heart failure | 1977 |
Enalapril | tablet | ACE inhibitors used to treat heart failure | 2003 |
Furosemide | Injection, juice, tablet | Loop diuretic used to treat heart failure | 2005 |
Hydrochlorothiazide | Capsule, juice, tablet | Thiazide diuretic used to treat heart failure | 1988 |
Losartan | tablet | AT 1 antagonist for the treatment of heart failure | |
Spironolactone | tablet | Potassium sparing diuretic used to treat elevated aldosterone levels and to treat heart failure | 2013 |
Dopamine (complementary) | injection | Treatment of severe cardiogenic shock | 1977 |
12.5 Antithrombotic Drugs | |||
12.5.1 Anti- platelet drugs | |||
Acetylsalicylic acid | tablet | Prevention of platelet aggregation, prophylaxis in circulatory disorders of the brain and coronary artery disease | 1992 |
Clopidogrel | tablet | Inhibition of platelet aggregation | |
12.5.2 Thrombolytic Drugs | |||
Alteplase (complementary) | Powder for injection | 2019 | |
Streptokinase (complementary) | Powder for injection | Treatment of acute myocardial infarction , leg vein thrombosis , pulmonary embolism and thrombosed shunts | 1992 |
12.6 Lipid lowering agents | |||
Simvastatin | tablet | Treatment of high cholesterol in high- risk patients | 2007 |
13 Dermatological Medicines for Topical Use
Surname | recommended form of application | World Health Organization indications | Year of admission |
---|---|---|---|
13.1 Anti-fungal agents ( antimycotics ) | |||
Miconazole | Ointment, cream | Treatment of superficial fungal infections | 1977 |
Sodium thiosulfate | solution | Treatment of pityriasis versicolor | 1992 |
Selenium disulfide | suspension | Treatment of pityriasis versicolor and seborrheic dermatitis | 1990 |
Terbinafine | Ointment , cream | 2011 | |
13.2 Active ingredients against infections | |||
Mupirocin | Ointment, cream | 2011 | |
Potassium permanganate | Aqueous solution | Moist dressings for the healing of purulent wounds, tropical ulcers , tinea , diseases of the pemphigus group and impetigo contagiosa | 1997 |
Silver sulfadiazine | cream | Prophylaxis and treatment of infections in burns | 1988 |
13.3 Active substances against inflammation and itching | |||
Betamethasone | Ointment, cream | Potent topical corticosteroid , used in severe inflammatory skin conditions such as contact dermatitis , eczema , seborrheic dermatitis , lichen planus , persistent itching , psoriasis | 1977 |
Calamine | lotion | Treatment of mild itching | 1983 |
Hydrocortisone | Ointment, cream | Mild topical corticosteroid | 1977 |
13.4 Active ingredients that affect skin differentiation and proliferation | |||
Benzoyl peroxide | Lotion, cream | Treatment of acne vulgaris | 1990 |
Coal tar | solution | Treatment of psoriasis | 1977 |
Fluorouracil | ointment | Treatment of warts on the soles of the feet | 1990 |
Podophyllum | solution | Treatment of warts on the genital area and the soles of the feet | 1985 |
Salicylic acid | solution | Treatment of warts on the soles of the feet | 1979 |
urea | Ointment, cream | Keratolytic and Hautanfeuchtendes agents in dry, cracked and itchy skin conditions | 1997 |
13.5 Remedies for lice and scabies | |||
Benzyl benzoate | lotion | Treatment of scabies and lice on the head, trunk and pubic hair (alternatives are crotamiton , lindane , malathion and thiabendazole ) | 1979 |
Permethrin | Cream, lotion | Treatment of scabies and lice | 1977 |
14 Diagnostic Tools
Surname | recommended form of application | World Health Organization indications | Year of admission |
---|---|---|---|
14.1 Active ingredients in ophthalmology | |||
Fluorescein | eye drop | Diagnosis of lesions and foreign objects in the eye | 1979 |
Tropicamide | eye drop | Short-acting mydriatic for an ophthalmoscope | 1988 |
14.2 Contrast Media | |||
Amidotrizoic acid | injection | Ionic iodine-containing contrast agent for the representation of blood vessels , urinary and biliary tract and joints . | 1977 |
Barium sulfate | Aqueous suspension | Barium-containing contrast agent to visualize the gastrointestinal tract (single and double contrast methods , computer tomography ) | 1977 |
Iohexol | injection | Non-ionic iodine-containing contrast agent | 2000 |
Barium sulfate (complementary) | Aqueous solution | Barium-containing contrast agent to visualize the gastrointestinal tract (single and double contrast methods , computer tomography ) | 1977 |
Iotroxate dimeglumine (complementary) | solution | Contrast media | 1985 |
15 disinfectants
Surname | recommended form of application | World Health Organization indications | Year of admission |
---|---|---|---|
15.1 Antiseptics | |||
Chlorhexidine | solution | Antiseptic , disinfection of clean instruments | 1979 |
Ethanol | solution | Skin disinfection before injections and vascular punctures as well as surgical procedures | 2000 |
Povidone iodine | solution | Skin disinfection, antiseptic | 1979 |
15.2 Disinfectants | |||
Alcoholic hand rub | solution | Skin disinfection with 80% ethanol or 75% isopropanol | |
In chlorine -based agent | powder | Disinfection of surfaces and instruments | 1992 |
Chloroxylenol | solution | Disinfection of surfaces and instruments | 1998 |
Glutaral | solution | Disinfection and sterilization of instruments and surfaces | 1992 |
16 diuretics
17 Gastrointestinal Drugs
Surname | recommended form of application | World Health Organization indications | Year of admission |
---|---|---|---|
Pancreatic enzymes (complementary) | age dependent | 2019 | |
17.1 Antacids and anti-gastric agents | |||
Omeprazole | Powder for injection, solid or liquid oral forms | (Treatment of ulcer diseases) | 2009 |
Ranitidine | Injection, juice, tablet | Treatment of ulcer diseases ( stomach ulcer , duodenal ulcer ) | 2003 |
17.2 Active ingredients against nausea (anti- emetics ) | |||
Dexamethasone | Injection, capsule, juice, tablet | 2009 | |
Metoclopramide | Injection, juice, tablet | Treatment of nausea and vomiting for gastrointestinal diseases, migraines or radio / chemotherapy | 1985 |
Ondansetron | Injection, capsule, juice, tablet | 2009 | |
Aprepitant (complementary) | Capsule, soluble powder as juice | 2019 | |
17.3 Anti-Inflammatory Agents | |||
Sulfasalazine | Enema, tablet, suppository | Treatment and maintenance of remission of chronic inflammatory bowel diseases ( Crohn's disease , ulcerative colitis ) | 1988 |
Hydrocortisone (complementary) | Enema, suppository | Treatment of ulcerative colitis | 1988 |
17.4 Laxatives | |||
Senna | tablet | Treating constipation ( constipation ) | 1977 |
05.17 medicines for the treatment of diarrhea ( diarrhea ) | |||
Zinc sulfate | Soluble powder, capsule, tablet | Complementary treatment for acute and chronic diarrhea in children | 2005 |
17.5.1 Oral rehydration | |||
Oral rehydration salts | Soluble powder | Replacement of water and electrolyte losses in acute diarrheal diseases | k. A. |
17.5.2 Drugs for treating diarrhea | |||
Zinc sulfate | Capsule, tablet | Complementary treatment for acute and chronic diarrhea in children | 2005 |
18 hormones, endocrine active drugs and contraceptives
Surname | recommended form of application | World Health Organization indications | Year of admission |
---|---|---|---|
18.1 Adrenal Hormones and Synthetic Substitutes | |||
Fludrocortisone | tablet | (Artificial mineralocorticoid to compensate for an aldosterone deficiency) | 2009 |
Hydrocortisone | tablet | 2009 | |
18.2 Androgens | |||
Testosterone (complementary) | injection | Underactive gonads ( hypogonadism ) | 1977 |
18.3 Estrogens | |||
18.4 Progestagens | |||
Medroxyprogesterone acetate | tablet | Treatment of benign bleeding disorders of the uterus, endometriosis | 1995 |
18.5 Treatment of Diabetes Mellitus | |||
18.5.1 insulins | |||
insulin | injection | Treatment of insulin-dependent diabetes mellitus | 1977 |
Intermediate insulin ( NPH insulin , zinc insulin ) | injection | Treatment of insulin-dependent diabetes mellitus | 1985 |
18.5.2 Oral hypoglycemic agents | |||
Gliclazide | Capsule, tablet | Treatment of non-insulin dependent type 2 diabetes mellitus ; Replacement for glibenclamide as this is not suitable for patients over 60 years of age | 2013 |
Metformin | tablet | Treatment of non-insulin dependent type 2 diabetes mellitus | 1998 |
Metformin (complementary) | tablet | Treatment of non-insulin dependent type 2 diabetes mellitus | 1998 |
18.6 hypoglycemia | |||
Glucagon | injection | (Treatment of hypoglycaemia ) | 2011 |
Diazoxide (complementary) | Juice, tablet | 2019 | |
18.7 Thyroid Medicines | |||
L-thyroxine | tablet | Therapy of underactive thyroid ( hypothyroidism ) | 1977 |
Potassium iodide | tablet | Thyrotoxic crisis | 1979 |
Propylthiouracil | tablet | Therapy of overactive thyroid gland ( hyperthyroidism ) | 1979 |
Thiamazole | tablet | 2019 | |
Iodine potassium iodide solution (complementary) | juice | 2009 | |
Potassium iodide (complementary) | tablet | 2019 | |
Propylthiouracil (complementary) | tablet | Therapy of overactive thyroid gland ( hyperthyroidism ) | 1979 |
Thiamazole (complementary) | tablet | 2019 |
19 Immunologically effective drugs
Surname | recommended form of application | World Health Organization indications | Year of admission |
---|---|---|---|
19.1 Diagnostic agents | |||
Tuberculin test with purified tuberculin | injection | Intradermal injection as a diagnostic test for tuberculin response | 1977 |
19.2 Antisera and Immunoglobulins | |||
Antivenome -immunoglobulin | injection | Neutralization of snake poisons in patients who show symptoms of the disease ( blood clotting disorders , shock , nerve damage , muscle damage , kidney damage , pronounced swelling, rapid spread of symptoms). The antidotes must be adapted to the local snake population. | 1977 |
Diphtheria antitoxin | injection | Passive immunization in cases of suspected diphtheria | 1977 |
19.3 Vaccines | |||
Vaccines against tuberculosis ( Bacillus Calmette-Guérin ), cholera , diphtheria , dengue fever , encephalitis , hepatitis A , hepatitis B , Haemophilus influenzae , human papillomaviruses , influenza , Japanese encephalitis , Measles , Meningococcal , mumps , pertussis , pneumococci , polio , rabies , rotavirus , Rubella , tetanus , typhus , varicella , yellow fever |
20 muscle relaxants and cholinesterase inhibitors
Surname | recommended form of application | World Health Organization indications | Year of admission |
---|---|---|---|
Atracurium | injection | (non-depolarizing muscle relaxant in surgical procedures ) | 2011 |
Neostigmine | Injection, tablet | Antagonizing nondepolarizing muscle relaxants; Treatment of myasthenia gravis | 1977 |
Suxamethonium | Injection, powder for injection | Depolarizing muscle relaxant | 1977 |
Vecuronium | Powder for injection | nondepolarizing muscle relaxant in surgical procedures | 1993 |
Pyridostigmine (complementary) | Injection, tablet | Treatment of myasthenia gravis ; Antagonization of non-depolarizing muscle relaxants | 1979 |
Vecuronium (complementary) | Powder for injection | nondepolarizing muscle relaxant in surgical procedures | 1993 |
21 preparations for ophthalmology
Surname | recommended form of application | World Health Organization indications | Year of admission |
---|---|---|---|
21.1 Active ingredients against infections | |||
Acyclovir | ointment | Treatment of herpes-related inflammation of the cornea ( keratitis ) and systemic infections | 2007 |
Erythromycin | ointment | Chlamydia trachomatis or Neisseria gonorrhoea infections | |
Azithromycin | eye drop | bacterial infections of the eye | 2013 |
Gentamicin | eye drop | bacterial infections of the conjunctiva ( conjunctivitis ), inflammation of the eyelids ( blepharitis ) | 1990 |
Natamycin | eye drop | 2017 | |
Ofloxacin | eye drop | bacterial infections of the conjunctiva (conjunctivitis), inflammation of the eyelids (blepharitis) | 2013 |
Tetracycline | Eye ointment | Superficial bacterial infections of the eye, treatment of trachoma , prophylaxis of gonoblennorrhea in the newborn | 1977 |
21.2 Anti-inflammatory agents | |||
Prednisolone | eye drop | short-term treatment of inflammation of the eye | 1990 |
21.3 Local anesthetics | |||
Tetracaine | eye drop | Surface anesthesia of the eyelid and conjunctiva | 1977 |
21.4 Miotics and active ingredients for the treatment of glaucoma | |||
Acetazolamide | tablet | Treatment of chronic open-angle glaucoma , treatment of acute narrow-angle glaucoma | 1977 |
Latanoprost | eye drop | Treatment of glaucoma , increased pressure in the eye | 2013 |
Pilocarpine | eye drop | Treatment of chronic open-angle glaucoma, treatment of acute narrow-angle glaucoma, antagonization of mydriatic drugs | 1977 |
Timolol | eye drop | Increased intraocular pressure, chronic open-angle glaucoma, secondary glaucoma | 1985 |
21.5 Mydriatics | |||
Atropine | eye drop | Long-acting therapeutic mydriatic | 1977 |
Adrenaline (complementary) | eye drop | Reduction of eye pressure, mydriatic . Use in cases of increased eye pressure, chronic open-angle glaucoma | 1979 |
21.6 Vascular Endothelial Growth Factor (VEGF) | |||
Bevacizumab (complementary) | injection | age- related macular degeneration | 2013 |
22 Reproductive Health and Perinatal Care
Surname | recommended form of application | World Health Organization indications | Year of admission |
---|---|---|---|
22.1 Contraceptives | |||
22.1.1 Oral contraceptives | |||
Ethinyl estradiol + levonorgestrel | tablet | Oral contraception ( birth control pills ) | 1979 |
Ethinyl estradiol + norethisterone | tablet | Oral contraception | 1977 |
Levonorgestrel | tablet | Oral contraception. Emergency oral contraception | 1997 |
Ulipristal | tablet | Emergency oral contraception | 2017 |
22.1.2 Injectable contraceptives | |||
Estradiol 17β-cipionate + medroxyprogesterone acetate | injection | Short-term (progesterone / estrogen) contraception | 2007 |
Medroxyprogesterone acetate | Depot injection | Long-acting contraception | 1985 |
Norethisterone enanthate | solution | Long-acting contraception | 1985 |
22.1.3 intrauterine device | |||
Intrauterine device containing copper | ( Intrauterine ) contraception | 1988 | |
Levonorgestrel- releasing intrauterine device | ( Intrauterine ) contraception | ||
22.1.4 Mechanical contraception | |||
condom | Mechanical contraception | 1988 | |
Diaphragm | Mechanical contraception | 1988 | |
22.1.5 Implantable Contraceptives | |||
Etonogestrel -releasing implant | Long-term contraception ( progestin- based) | ||
Levonorgestrel -releasing implant | Long-term contraception (progestin-based) | k. A. | |
22.1.6 Intravaginal contraceptives | |||
Progesterone vaginal ring | For contraception during breastfeeding | ||
22.2 Induction of Ovulation | |||
Clomiphene (complementary) | tablet | 2019 | |
22.3 Oxytocins | |||
Carbetocin | injection | 2019 | |
Ergometrist | injection | Induction or intensification of labor , treatment of bleeding after childbirth, as an alternative or in addition to oxytocin | 1977 |
Mifepristone + misoprostol | tablet | Termination of pregnancy ("Where permitted by law and culturally accepted") | 2005 |
Misoprostol | Tablet, vaginal tablet | Induction of timely contractions, abortion expulsion | 2005 |
Oxytocin | injection | Induction or intensification of labor, treatment of bleeding after childbirth | 1977 |
22.4 labor inhibitors ( tocolytics ) | |||
Nifedipine | capsule | Prevention of Premature Labor | 2005 |
22.5 Medicines for the mother | |||
Dexamethasone | injection | 2013 | |
Tranexamic acid | injection | 2019 | |
22.6 Medicines for the newborn | |||
Caffeine citrate | Injection, juice | 2007 | |
Chlorhexidine | Solution or gel | Care of the umbilical cord | 2013 |
Ibuprofen (complementary) | Solution for injection | 2009 | |
Prostaglandins E1 and E2 (complementary) | Solution for injection | 2009 | |
Surfactant (complementary) | Solution for intratracheal instillation | 2009 |
23 Peritoneal Dialysis Solutions
Surname | recommended form of application | World Health Organization indications | Year of admission |
---|---|---|---|
intraperitoneal dialysis solution (complementary) | Solution of adequate composition | Maintenance of fluid and electrolyte balance in patients with acute or chronic kidney failure | 1977 |
24 psychotropic drugs
Surname | recommended form of application | World Health Organization indications | Year of admission |
---|---|---|---|
24.1 Antipsychotic Drugs | |||
Chlorpromazine | Injection, juice, tablet | Treatment of schizophrenia and other psychoses | 1977 |
Fluphenazine | injection | Maintenance treatment of schizophrenia and other psychoses | 1977 |
Haloperidol | Injection, tablet | Schizophrenia and other psychoses, mania , psychomotor restlessness and aggressive behavior , in combination therapy for severe anxiety disorders | 1977 |
Risperidone | Capsule, tablet | Treatment of schizophrenia | 2013 |
Chlorpromazine (complementary) | Injection, juice, tablet | Treatment of schizophrenia and other psychoses | 1977 |
Clozapine (complementary) | Capsule, tablet | Treatment of therapy-resistant psychoses | 2013 |
Haloperidol (complementary) | Injection, juice, capsule | Schizophrenia and other psychoses, mania , psychomotor restlessness and aggressive behavior , in combination therapy for severe anxiety disorders | 1977 |
24.2 Medicines for mood disorders | |||
24.2.1 Treatment of Depression | |||
Amitriptyline | tablet | Tricyclic antidepressant used to treat moderate and severe depression , neuropathic pain | 1977 |
Fluoxetine | Capsule, tablet | Treatment of moderate and severe depression | 2007 |
Fluoxetine (complementary) | Capsule, tablet | Treatment of moderate and severe depression | 2007 |
24.2.2 Treatment of Bipolar Disorder | |||
Carbamazepine | tablet | Prophylaxis of bipolar disorder in the absence of response to lithium | 1998 |
Lithium carbonate | Capsule, tablet | Prophylaxis and treatment of bipolar (manic-depressive) disorders | 1977 |
Valproic acid | tablet | Treatment of Manic Episodes of Bipolar Disorder | 1998 |
24.3 Medication for Anxiety | |||
Diazepam | tablet | Long-acting benzodiazepine for releasing anxiety ( anxiolysis ) and promoting sleep | 1977 |
24.4 Medication for Obsessive Compulsive Disorder | |||
Clomipramine | capsule | Control of panic attacks and obsessive-compulsive disorder | 1995 |
24.5 Medication for addictions | |||
Nicotine replacement therapy | Chewing gum, band-aid | 2009 | |
Methadone (complementary) | juice | Treatment of opioid dependence as part of fixed programs (alternatively buprenorphine ) | 2005 |
25 Substances effective in the respiratory tract
Surname | recommended form of application | World Health Organization indications | Year of admission |
---|---|---|---|
25.1 Drugs for the treatment of bronchial asthma and chronic obstructive pulmonary disease (COPD) | |||
Beclometasone | Inhalation as an aerosol | Inhaled corticosteroid for use in bronchial asthma and COPD | 1990 |
Budesonide | Inhalation as an aerosol | (Inhaled corticosteroid for use in bronchial asthma and COPD) | 2009 |
Budesonide + formoterol | Powder for inhalation | ||
adrenaline | injection | Treatment of acute asthma attacks when beta-2 sympathomimetics have failed | 1977 |
Ipratropium bromide | Inhalation as an aerosol | Chronic bronchial asthma, COPD | 1998 |
Salbutamol | Inhalation (aerosol, nebulizer), injection | Therapy and prophylaxis of bronchial asthma and other airway obstruction | 1977 |
Tiotropium | Inhalation powder or solution, capsule | 2019 |
26 solutions for the treatment of disorders of the water, electrolyte and acid-base balance
Surname | recommended form of application | World Health Organization indications | Year of admission |
---|---|---|---|
26.1 Peroral | |||
Oral rehydration salts | soluble powder | Replacement of salt and water loss in diarrhea (diarrhea) | k. A. |
Potassium chloride | soluble powder | Avoidance and treatment of potassium deficiency , especially with diuretic therapy | 1977 |
26.2 Parenteral | |||
glucose | Solution for injection | Fluid replacement with normal electrolyte concentrations, treatment of low blood sugar (hypoglycaemia) | 1977 |
Glucose with sodium chloride | Solution for injection | Fluid and electrolyte replacement | 1979 |
Potassium chloride | Solution for injection | Prevention and treatment of potassium deficiency | 1977 |
Sodium chloride | Solution for injection | Infusion therapy for fluid and electrolyte replacement | 1977 |
Sodium hydrogen carbonate | Solution for injection | Treatment of Metabolic Acidosis | 1977 |
Sodium lactate , combination solution | Solution for injection | Infusion therapy before and during surgery , volume deficiency shock | 1977 |
26.3 Miscellaneous | |||
Water for injections | injection | For dissolving and diluting, filled into ampoules. | 1977 |
27 vitamins and minerals
Surname | recommended form of application | World Health Organization indications | Year of admission |
---|---|---|---|
Ascorbic acid (vitamin C) |
tablet | Prophylaxis and therapy of scurvy | 1979 |
Cholecalciferol (Vitamin D 3 ) |
Capsule, juice, tablet | 2011 | |
Ergocalciferol (vitamin D 2 ) |
Capsule, juice, tablet | Prophylaxis and therapy of vitamin D deficiency in malabsorption or chronic liver diseases, calcium deficiency in hypoparathyroidism | 1977 |
Iodine | iodinated oil, capsule |
Goiter prophylaxis in iodine deficient areas where the need is not covered by iodine salt | 1990 |
Nicotinamide (vitamin B 3 ) |
tablet | Prophylaxis and therapy of nicotinamide deficiency | 1977 |
Multi-micronutrient powder | Sachet | contains iron, zinc and vitamin A. | 2019 |
Pyridoxine (vitamin B 6 ) |
tablet | Treatment of pyroxidine deficiency due to metabolic diseases, nerve damage from isoniazid , sideroblastic anemia | 1979 |
Retinol (vitamin A) |
Capsule, oily drink solution, tablet, water-miscible injection | Prophylaxis and therapy of retinol deficiency, avoidance of complications of measles | 1977 |
Riboflavin (vitamin B 2 ) |
tablet | Therapy of riboflavin deficiency | 1977 |
Sodium fluoride | topical formulation | Prevention of tooth decay | 1979 |
Thiamine (vitamin B 1 ) |
tablet | Prophylaxis and therapy of thiamine deficiency | 1977 |
Calcium gluconate (complementary) | injection | Therapy of tetany due to calcium deficiency | 1998 |
28 Treatment of ENT diseases in childhood
Surname | recommended form of application | World Health Organization indications | Year of admission |
---|---|---|---|
acetic acid | Topical formulation | 2009 | |
Budesonide | Nasal spray | 2009 | |
Ciprofloxacin | Topical formulation | 2009 | |
Xylometazoline | Nasal spray | 2009 |
29 active ingredients for joint diseases
Surname | recommended form of application | World Health Organization indications | Year of admission |
---|---|---|---|
29.1 Active ingredients for the treatment of gout | |||
Allopurinol | tablet | Treatment of gout | 1977 |
29.2 Basic therapy for rheumatic diseases | |||
Chloroquine | tablet | Treatment of the progression of diseases of the rheumatic type | 1998 |
Azathioprine (complementary) | tablet | Second-line drug if another drug is not effective | 1998 |
Hydroxychloroquine (complementary) | capsule | Alternative to chloroquine | 2011 |
Methotrexate (complementary) | tablet | Immunosuppressant , diseases of the rheumatic type | 1998 |
Penicillamine (complementary) | Capsule or tablet | Treatment of the progression of diseases of the rheumatic type | 1998 |
Sulfasalazine (complementary) | tablet | Treatment of the progression of severe rheumatoid arthritis | 1998 |
29.3 Treatment of juvenile joint disease | |||
Acetylsalicylic acid (complementary) | Tablet, suppository | rheumatic fever, youth rheumatism, Kawasaki syndrome | 2013 |
Notes and references
- ↑ For the explanations cf. WHO Model List of Essential Medicines. 16th list, March 2009. Explanatory Notes.
- ↑ a b c d e f g h i j k l m n o p q r s t u v w x y z aa ab ac ad ae af ag ah ai aj ak al am an ao ap aq ar as at au av aw ax ay az ba bb bc bd be bf bg bh bi bj bk bl bm bn bo bp bq br bs bt bu bv bw bx by bz ca cb cc cd ce cf cg ch ci cj ck cl cm cn co cp cq cr cs ct cu cv cw cx cy cz da db dc dd de df dg dh di dj Marking with the square box symbol (□): It is also possible to use an alternative active ingredient with comparable therapeutic properties and the same safety in use. This should be determined when the list is adopted and adapted to national circumstances based on these considerations and based on the price and availability.
- ↑ a b c d e f g h i j k l m n o p q r s t u v w x y z aa ab ac ad ae af ag ah ai aj ak al am an ao ap aq ar as at au av aw ax ay az ba bb bc bd be bf bg bh bi bj bk bl bm bn bo bp bq br bs bt bu bv bw bx by bz ca cb cc cd ce cf cg ch ci cj ck cl cm There is no indication in the WHO database listed
- ↑ Due to the specific indications, no such individual or other details are listed in the WHO database. The list is based on recommendations of the Strategic Advisory Group of Experts on Immunization (SAGE) or WHO position papers . The choice of vaccines should be based on the epidemiology of the diseases, national priorities and international recommendations.
literature
All data in the article are based on the original English list, the contents of which are also recorded in the WHO online database:
- WHO Model List of Essential Medicines. 15th list, March 2007. ( PDF, 370 kB )
- WHO Model List of Essential Medicines. 16th list, March 2009. ( PDF, 670 kB )
- WHO Model List of Essential Medicines. 17th list, March 2011. ( PDF, 431 kB )
- WHO Model List of Essential Medicines. 18th list, April 2013. (PDF)
- WHO Model List of Essential Medicines. 19th list, April 2015. ( PDF )
- WHO Model List of Essential Medicines. 20th list, March 2017, including corrections from August 2017 ( PDF )
- WHO Model List of Essential Medicines. 21th list, June 2019 ( PDF )
Others
The pharmaceutical company Ciba-Geigy took the creation of the first list in 1977 as an opportunity to found its own generic line ( Servipharm ).
Web links
Individual evidence
- ↑ Milton Silverman, Mia Lydecker, Philip R. Lee: Bad Medicine: The Prescription Drug Industry in the Third World . Stanford University Press, 1992, ISBN 978-0-8047-6667-8 , pp. 165-166 ( Google Books ).
- ↑ Milton Silverman, Mia Lydecker, Philip R. Lee: Prescriptions for Death: The Drugging of the Third World . University of California Press, 1982, ISBN 978-0-520-04721-1 ( Google Books ).